SOPHiA Genetics Reports Fourth Quarter and Full Year 2024 Results

Reuters
04 Mar
March 4 (Reuters) - Sophia Genetics SA <90B.F>::
*SOPHIA GENETICS SA - 2025 REVENUE GUIDANCE $72 MILLION TO $76 MILLION
*SOPHIA GENETICS SA - Q4 REVENUE $17.7 MILLION, UP 4% YEAR-OVER-YEAR
*SOPHIA GENETICS SA: EXPECTS TO BE APPROACHING ADJUSTED EBITDA BREAKEVEN BY END OF 2026 & CROSSING OVER TO POSITIVE ADJUSTED EBITDA IN H2 OF 2027
*SOPHIA GENETICS SA: QTRLY NET LOSS 0.23 PER SHARE

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 04-MAR-202511:45:03.54 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10